
Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

